Approval · Notice of Compliance 22367 · 2019
MESTINON: Notice of Compliance 22367
Issued July 4, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22367
- Date
- July 4, 2019
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MESTINON | 00869961 | Marketed |
| MESTINON-SR | 00869953 | Marketed |
Medicinal ingredients
- PYRIDOSTIGMINE BROMIDE 60 MG per TAB
- PYRIDOSTIGMINE BROMIDE 180 MG per TAB